0001231919-25-000517.txt : 20251118
0001231919-25-000517.hdr.sgml : 20251118
20251118153342
ACCESSION NUMBER: 0001231919-25-000517
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20251118
DATE AS OF CHANGE: 20251118
EFFECTIVENESS DATE: 20251118
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dualitas Therapeutics, Inc.
CENTRAL INDEX KEY: 0002091994
ORGANIZATION NAME:
EIN: 922141988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-564321
FILM NUMBER: 251494243
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BOULEVARD, SUITE 411
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (917) 640-1086
MAIL ADDRESS:
STREET 1: 681 GATEWAY BOULEVARD, SUITE 411
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0002091994
Dualitas Therapeutics, Inc.
681 GATEWAY BOULEVARD, SUITE 411
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
(917) 640-1086
DELAWARE
None
None
Corporation
true
2023
Richard
Murray
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Forbes
Huang
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Nikola
Trbovic
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Director
Neil
Weir
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Director
Alicia
Levey
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Director
Thomas
Hudson
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Director
Mark
McDade
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Director
Greg
Lazar
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Michael
Ross
c/o Dualitas Therapeutics, Inc.
681 Gateway Boulevard, Suite 411
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2025-07-07
false
true
false
0
66599990
32599997
33999993
Includes conversion of $15,600,000 in simple agreements for future equity.
false
7
0
0
0
false
Dualitas Therapeutics, Inc.
/s/ Richard Murray
Richard Murray
President
2025-11-18